SS
CBAY

Steve Schonfeld’s Cymabay Therapeutics CBAY Stock Holding History

Steve Schonfeld’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-244,620
Closed -$3.65M – 2331
2023
Q3 		$3.65M Buy
244,620
+173,938
+246% +$2.31M 0.03% 639
2023
Q2 		$774K Buy
+70,682
New +$658K 0.01% 1066
2023
Q1 		– Sell
-121,683
Closed -$763K – 2820
2022
Q4 		$763K Buy
+121,683
New +$462K 0.01% 1297
2021
Q3 		– Sell
-15,003
Closed -$65K – 2561
2021
Q2 		$65K Buy
+15,003
New +$66.5K ﹤0.01% 1861
2020
Q4 		– Sell
-501,368
Closed -$3.63M – 1950
2020
Q3 		$3.63M Buy
501,368
+420,986
+524% +$2.25M 0.07% 366
2020
Q2 		$281K Buy
80,382
+24,132
+43% +$69.6K 0.01% 1016
2020
Q1 		$83K Buy
+56,250
New +$94.4K 0.01% 1022
2019
Q4 		– Sell
-77,800
Closed -$398K – 1532
2019
Q3 		$398K Sell
77,800
-494,400
-86% -$2.99M 0.01% 709
2019
Q2 		$4.1M Buy
572,200
+268,800
+89% +$3.04M 0.14% 172
2019
Q1 		$4.03M Buy
303,400
+281,200
+1,267% +$2.99M 0.14% 194
2018
Q4 		$175K Buy
22,200
+8,200
+59% +$78K 0.01% 962
2018
Q3 		$156K Sell
14,000
-12,000
-46% -$149K 0.01% 765
2018
Q2 		$349K Buy
+26,000
New +$325K 0.02% 605
2017
Q4 		– Sell
-34,410
Closed -$278K – 917
2017
Q3 		$278K Buy
+34,410
New +$233K 0.03% 468

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steve Schonfeld's CBAY Position: Q4 2023 in Review

Steve Schonfeld sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 244,620 shares — an estimated $3.65M sold.

Steve Schonfeld first reported a position in CBAY in Q3 2017 and held it in 14 quarters. The position peaked at $4.1M in Q2 2019. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.

  • Steve Schonfeld reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Steve Schonfeld sold 244,620 Cymabay Therapeutics shares in Q4 2023, an estimated $3.65M.
  • Steve Schonfeld first reported a position in Cymabay Therapeutics in Q3 2017 and held it in 14 quarters.
  • Steve Schonfeld's Cymabay Therapeutics position peaked at $4.1M in Q2 2019.
  • 200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.